REQUEST FOR TRADING HALT anyone watching this ??
Fiji Kava Limited (Fiji Kava) requests an immediate trading halt be granted by ASX in respect
of its ordinary shares from the commencement of trading on Wednesday 16 October 2019.
The trading halt is requested pending an announcement by Fiji Kava in relation to a
Memorandum of Understanding to sell product though a major pharmacy group into New
In accordance with ASX Listing Rule 17.1, Fiji Kava provides the following information.
• Fiji Kava requests that the trading halt continue until the earlier of commencing of
normal trading on Friday 18 October 2019 and when Fiji Kava makes an
announcement to the market and requests the trading halt be lifted; and
• Fiji Kava is not aware of any reason why the trading halt should not be granted.
courtesy of Bell Direct
( DYOR )
i do not hold this share ( and in no way should you consider this recommendation from me )
had some neighbours from Fiji that used to drink and party with this stuff , i am not sure about the 'medical benefits , but pot is now OK as a product so maybe this will go somewhere as well
FIJI KAVA SIGNS AGREEMENT WITH NEW ZEALAND’S
LEADING PHARMACY GROUP, GREEN CROSS HEALTH
• Fiji Kava has signed a Memorandum of Understanding with leading New Zealand pharmacy
group, Green Cross Health. This significantly strengthens Fiji Kava’s market presence in New
Zealand by providing direct access to consumers through an established pharmacy network.
• Fiji Kava capsules and kava powder mixes to be available in up to 200 of Green Cross Health’s
Life Pharmacies and Unichem Pharmacies across New Zealand from October 2019.
• Fiji Kava is the first foreign company to be granted approval by the Fijian Government to
operate in the kava industry, giving the company a unique leadership position in a market with
high barriers to entry. Fiji Kava was the first kava company to publicly list on the ASX
17 October 2019 – Brisbane, Australia – Fiji Kava Ltd (ASX: FIJ), an Australian-Fijian medicinal kava
company, today announced the signing of a Memorandum of Understanding with Green Cross Health
(NZX: GXH) to market and sell Fiji Kava products across its significant nation-wide pharmacy network
in New Zealand.
Green Cross Health is a leading professional health care provider listed on the New Zealand Stock
Exchange, with an extensive network of more than 350 pharmacies across its Unichem and Life
Under the terms of the Memorandum of Understanding, Fiji Kava’s capsules and instant kava powder
mixes will be available in up to 200 Green Cross Health pharmacies from October 2019. The initial
launch of products will include kava capsules and kava powder mixes.
The Memorandum of Understanding provides Green Cross Health with exclusivity to sell Fiji Kava
products to its New Zealand pharmacies for a 12-month period, with the option to increase
distribution to its entire pharmacy network during the course of the arrangement.
Fiji Kava founder and Managing Director, Zane Yoshida said: “There is a major resurgence of global
demand for kava as anxiety disorders and depression continues to grow in our society, and New
Zealand and its strong Pacific Island population is central to the growth in kava demand.
“Kava is a product designed to target areas such as stress and anxiety relief, so pharmacies represent
the perfect placement channel for Fiji Kava’s products. We are extremely excited to finalise this
strategic agreement with New Zealand’s leading national pharmacy group, which significantly
enhances our reach in New Zealand and continues our growth across global markets.”
Green Cross Health General Manager Operations and Merchandise, Jason Reeves said: “In New
Zealand, as in other Western markets, stress and anxiety is a growing concern. Kava is becoming far
more prevalent as a ‘plant-based’ natural alternative to addressing these issues, especially in New
Zealand where there is a significant Pacific Island community. We're very excited to work with Fiji Kava
in fulfilling this demand, to provide our customers and consumers with high-quality, natural and
sustainable kava products.”
Demand for Fijian kava in New Zealand has increased in recent years, with New Zealand and the US
combined to account for 75% of the value of all exported Fijian kava over the past five years. Globally,
exported Fijian kava has experienced average annual growth of 32% during the same five-year period.
Following a period of initial infrastructure and supply chain establishment, Fiji Kava launched its global
retail activities with an online presence in key markets of Australia, New Zealand, Fiji and the US. The
Memorandum of Understanding with Green Cross Health supports a core strategic initiative of Fiji
Kava’s overall global retail strategy, as the company continues to build its omni-store retail presence
and the availability of its kava products range globally.
courtesy of Bell Direct
( DYOR )
i do not hold this share
gee sales v. R&D costs as they push for a wider market
but might be worth watching the next year's worth of financial reports
.09 could be an opening?